(Q32045383)

5 July 2017

1 reference

title

Pharmaceutical and therapeutic applications of artificial cells including microencapsulation (English)

1 reference

5 July 2017

1 reference

Chang TM

1

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

European Journal of Pharmaceutics and Biopharmaceutics

5 July 2017

published in

1 reference

5 July 2017

volume

45

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

3-8

1 reference

30th Anniversary in Artificial Red Blood Cell Research

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

SEMIPERMEABLE MICROCAPSULES

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Semipermeable aqueous microcapsules. I. Preparation and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Removal of endogenous and exogenous toxins by a microencapsulated absorbent

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Semipermeable Microcapsules containing Catalase for Enzyme Replacement in Acatalasaemic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

The in vivo Effects of Semipermeable Microcapsules containing L-Asparaginase on 6C3HED Lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Preparation and characterisation of xanthine oxidase immobilised by microencapsulation in artificial cells for the removal of hypoxanthine

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

MICROENCAPSULATED XANTHINE OXIDASE AS EXPERIMENTAL THERAPY IN LESCH-NYHAN DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Plasma/intestinal concentration patterns suggestive of entero-portal recirculation of amino acids: effects of oral administration of asparaginase, glutaminase and tyrosinase immobilized by microencapsulation in artificial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Microencapsulated islets as bioartificial endocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Hepatocytes immobilised by microencapsulation in artificial cells: effects on hyperbilirubinemia in Gunn rats

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Kinetic analysis of UDP-glucuronosyltransferase in bilirubin conjugation by encapsulated hepatocytes for transplantation into Gunn rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Repeated transplantation of microencapsulated hepatocytes for sustained correction of hyperbilirubinemia in Gunn rats

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

A Novel two Step Procedure for Immobilizing Living Cells in Microcapsules for Improving Xenograft Survival

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Artificial cells for bioencapsulation of cells and genetically engineered E. coli. For cell therapy, gene therapy, and removal of urea and ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0939-6411%2897%2900117-3

7 January 2021

10.1016/S0939-6411(97)00117-3

Identifiers

DOI

1 reference

5 July 2017

1 reference